Motus GI Holdings, Inc. (MOTS)
| Market Cap | 49.33M |
| Revenue (ttm) | 161,000 |
| Net Income (ttm) | -20.80M |
| Shares Out | 30.42M |
| EPS (ttm) | -0.71 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Dividend Yield | n/a |
| Trading Day | January 22 |
| Last Price | $1.53 |
| Previous Close | $1.61 |
| Change ($) | -0.08 |
| Change (%) | -4.97% |
| Day's Open | 1.50 |
| Day's Range | 1.39 - 1.57 |
| Day's Volume | 3,374,180 |
| 52-Week Range | 0.50 - 2.19 |
Regulatory approval for enhanced system is a key milestone that supports evaluation of strategic partnership opportunities in the EU - - - U.S. commercial rollout of Pure-Vu® GEN2 System enhan...
Receives additional EU Patent for the Pure-Vu® System that protects the design of its fecal waste evacuation channels Receives additional EU Patent for the Pure-Vu® System that protects the de...
FORT LAUDERDALE, Fla., Nov. 25, 2020 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc., (NASDAQ: MOTS) ("Motus GI" or the "Company"), a medical technology company providing endoscopy solutions that ...
Motus GI Holdings, Inc.'s (MOTS) CEO Tim Moran on Q3 2020 Results - Earnings Call Transcript
FORT LAUDERDALE, Fla., Nov. 12, 2020 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc., (NASDAQ: MOTS) ("Motus GI" or the "Company"), a medical technology company providing endoscopy solutions that ...
FORT LAUDERDALE, Fla., Nov. 03, 2020 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc. , (NASDAQ: MOTS) ("Motus GI" or the "Company"), a medical technology company providing endoscopy solutions to h...
FORT LAUDERDALE, Fla., Oct. 29, 2020 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc., (NASDAQ: MOTS) ("Motus GI" or the "Company"), a medical technology company providing endoscopy solutions that ...
FORT LAUDERDALE, Fla., Oct. 13, 2020 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc., (NASDAQ: MOTS) ("Motus GI" or the "Company"), a medical technology company providing endoscopy solutions that ...
FORT LAUDERDALE, Fla., Sept. 14, 2020 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc., (NASDAQ: MOTS) ("Motus GI" or the "Company"), a medical technology company providing endoscopy solutions th...
FORT LAUDERDALE, Fla., Sept. 10, 2020 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc. , (NASDAQ: MOTS) ("Motus GI" or the "Company"), a medical technology company providing endoscopy solutions ...
FORT LAUDERDALE, Fla., Aug. 28, 2020 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc., (NASDAQ: MOTS) ("Motus GI" or the "Company"), a medical technology company providing endoscopy solutions tha...
Motus GI Holdings, Inc.'s (MOTS) CEO Tim Moran on Q2 2020 Results - Earnings Call Transcript
Motus GI Holdings, Inc. (MOTS) delivered earnings and revenue surprises of 28.57% and -95.00%, respectively, for the quarter ended June 2020.
Shares of Motus GI Hldgs (NASDAQ: MOTS) were flat after the company reported Q2 results.
FORT LAUDERDALE, Fla., July 21, 2020 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc. , (NASDAQ: MOTS) ("Motus GI" or the "Company"), a medical technology company providing endoscopy solutions t...
FORT LAUDERDALE, Fla., June 15, 2020 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc., (NASDAQ: MOTS) ("Motus GI" or the "Company"), a medical technology company providing endoscopy solutions tha...
Live moderated video webcast discussion with CEO, Tim Moran on Monday, June 15, at 2:00 PM ET, immediately followed by an interactive Q&A session Live moderated video webcast discussion with C...
Motus GI Holdings, Inc. (MOTS) CEO Tim Moran on Q1 2020 Results - Earnings Call Transcript
Motus GI Holdings, Inc. (MOTS) delivered earnings and revenue surprises of -4.55% and -81.33%, respectively, for the quarter ended March 2020.
FORT LAUDERDALE, Fla., May 14, 2020 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc. , (NASDAQ: MOTS) ("Motus GI" or the "Company"), a medical technology company providing endoscopy solutions th...
FORT LAUDERDALE, Fla., May 05, 2020 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc., (NASDAQ: MOTS) ("Motus GI" or the "Company"), a medical technology company providing endoscopy solutions that...
Motus GI Holdings, Inc. (MOTS) CEO Tim Moran on Q4 2019 Results - Earnings Call Transcript
FORT LAUDERDALE, Fla., March 30, 2020 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc. , (NASDAQ: MOTS) ("Motus GI" or the "Company"), a medical technology company providing endoscopy solutions ...
As of late, it has definitely been a great time to be an investor in Motus GI Holdings.
Motus GI Holdings, Inc. (MOTS) CEO Tim Moran on Q3 2019 Results - Earnings Call Transcript
Motus GI Holdings, Inc. (MOTS) delivered earnings and revenue surprises of 28.00% and -97.00%, respectively, for the quarter ended September 2019.
About MOTS
Motus GI Holdings, a medical technology company, provides endoscopy solutions that enhance clinical outcomes and the cost-efficiency associated with the diagnosis and management of gastrointestinal conditions in the United States and Israel. Its flagship product is the Pure-Vu system, a medical device to facilitate the cleaning of a poorly prepared colon during the colonoscopy procedure. The company is based in Fort Lauderdale, Florida.
| Industry Diagnostics & Research | IPO Date Feb 14, 2018 |
| CEO Timothy Moran | Employees 49 |
| Stock Exchange NASDAQ | Ticker Symbol MOTS |
Financial Performance
In 2019, MOTS's revenue was $107,000, an increase of 197.22% compared to the previous year's $36,000. Losses were -$23.09 million, 3.72% more than in 2018.
Analyst Forecasts
According to 6 analysts, the average rating for MOTS stock is "Buy." The 12-month stock price forecast is 2.50, which is an increase of 63.40% from the latest price.